(Q37853833)

24 August 2017

1 reference

title

A fresh look at the mechanism of isoniazid-induced hepatotoxicity (English)

1 reference

24 August 2017

1 reference

0 references

I G Metushi

1

1 reference

24 August 2017

P Cai

2

1 reference

24 August 2017

X Zhu

3

1 reference

24 August 2017

T Nakagawa

4

1 reference

24 August 2017

J P Uetrecht

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

16 March 2011

1 reference

Clinical Pharmacology & Therapeutics

24 August 2017

1 reference

24 August 2017

89

1 reference

24 August 2017

911-914

1 reference

24 August 2017

6

1 reference

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

24 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Idiosyncratic liver injury: challenges and approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Systemic lupus erythematosus induced by isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Plasma hydrazine concentrations in man after isoniazid and hydralazine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

A mechanistic study on the oxidation of hydrazides: application to the tuberculosis drug isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

D-penicillamine-induced autoimmunity: relationship to macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Involvement of the immune system in idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

Immunoallergic drug-induced liver injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

7 January 2021

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

7 January 2021

Role of Hydrazine in Carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

7 January 2021

Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

7 January 2021

Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.355

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.355

1 reference

24 August 2017

1 reference